Abstract
Antidepressant drugs differ in their propensity to cause cardiac side-effects. Claimed advantages of a drug may channel it to patients with special pre-existing morbidity, with the consequence that patient characteristics may be confounded with drug effects. We measured the relative usage of the various antidepressant drugs in patients with and without cardiovascular disease, particularly to learn whether antidepressant drugs without cardiac side-effects were more likely to be prescribed for patients with concomitant cardiovascular conditions. Our primary data were the drug-dispensing records from Dutch community pharmacies, covering 1173 anonymized recipients of antidepressant drugs in a 6-month period. We interpreted as marker of cardiovascular disease the concomitant prescribing of major cardiovascular drugs, such as cardiac glycosides, beta blockers, calcium antagonists and the like. The differences in the percentage of recipients of antidepressant drugs concomitantly prescribed major cardiac agents were considerable. At the high end were mianserin (36%) and doxepin (35%); at the low end were fluoxetine (13%) and clomipramine (18%). When the data were stratified for age and sex, however, no significant residual differences remained with respect to cardiovascular co-medication. Thus, channeling occurs in some drugs, but apparently partly via the indirect way of age/sex differences of the recipients of the drugs.
| Original language | English |
|---|---|
| Pages (from-to) | 159-167 |
| Number of pages | 9 |
| Journal | Post Marketing Surveillance |
| Volume | 5 |
| Issue number | 2 |
| Publication status | Published - 1991 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- adverse drug reactions
- antidepressant drugs
- cardiac disease
- mental depression
- pharmacoepidemiology
Fingerprint
Dive into the research topics of 'Channeling of antidepressant drugs to patients with cardiovascular disease'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver